Differences Between Obstructive and Restrictive Lung Diseases

Definitions, Conditions, Diagnostic Testing, and Treatment

lungs on chest x-ray looking for obstructive vs restrictive lung disease
Spencer Platt/Getty Images News/Getty Images

One of the first steps in diagnosing lung diseases is differentiating between obstructive lung disease and restrictive lung disease. While both types of conditions can cause shortness of breath, obstructive lung diseases (such as asthma and COPD) cause more difficulty with exhaling air and restrictive lung diseases (such as pulmonary fibrosis) can cause problems by restricting a person's ability to inhale air.

It’s a difference that might not be apparent at first but one that can be differentiated by a battery of diagnostic tests which evaluate the capacity and forcefulness of person’s inhalation and exhalation. Treatments for the two categories of diseases differ, with therapy for obstructive diseases often focused on improving the obstruction, and treatments for restrictive diseases focusing on what is interfering with inhalation, whether due to a problem intrinsic or extrinsic to the lungs.


Though there are many different obstructive and restrictive lung diseases, there are some major characteristics that differ between the two.


Obstructive lung diseases are characterized by obstruction in the air passages, with obstruction defined by exhalation is that is slower and shallower than in someone without the disease. Obstruction can occur when inflammation and swelling cause the airways to become narrowed or blocked, making it difficult to exhale air from the lungs.

This results in an abnormally high volume of air being left in the lungs (increased residual volume). Increased residual volume, in turn, leads to both the trapping of air and hyperinflation of the lungs; changes that contribute to a worsening of respiratory symptoms.


In contrast to obstructive lung diseases, restriction is defined by inhalation that fills the lungs far less than would be expected in a healthy person.

Restrictive lung diseases are characterized by a reduced total lung capacity, or the sum of the residual volume mentioned above combined with the forced vital capacity (the amount of air that can be exhaled forcefully after taking a deep breath). This occurs because of difficulty filling the lungs completely in the first place, and can be due to intrinsic factors (stiff lungs), extrinsic factors (such as when pressure from an enlarged abdomen limits the expansion of the lungs), or neurological factors (such as muscular dystrophy), where damage to the nervous system interferes with movements necessary to draw air into the lungs.


There are both similarities and differences between obstructive and restrictive lung diseases with regard to symptoms, and these signs can also differ between the specific diseases in these categories. That said, there can be significant overlap in symptoms, and pulmonary function tests are often needed to make a diagnosis.

Obstructive and Restrictive Lung Disease

Shortness of breath, or the symptom of difficulty breathing called dyspnea, is common with both obstructive and restrictive lung diseases. Early on in the course of these diseases, dyspnea may occur primarily with activity, with symptoms at rest occurring in the more advanced stages.


Other symptoms that are common with both include a persistent cough  (though this is more common in conditions such as bronchitis and pneumonia), a rapid respiratory rate (tachypnea), anxiety (often due to difficulty breathing), and unintentional weight loss (due to the increased energy needed to breathe).


With obstruction, a person may have difficulty expelling all of the air from lungs. This often worsens with activity, since when respiratory rate increases, it becomes challenging to blow out all of the air in the lungs before taking the next breath. Narrowing of the airways may cause signs such as wheezing, and many of the conditions that fall under the category of obstructive lung disease are associated with increased sputum production as well.


With restrictive lung disease, a person may feel like it hard to take a full breath, and this can cause considerable anxiety at times. With extrinsic lung disease, a person may change positions trying to find a position that makes it easier to breathe.


Lung conditions can be broken down into those that are primarily obstructive and those that are primarily restrictive, though some people may have one or more conditions that fall into different categories (mixed). With some lung diseases, the condition causes one pattern early on, and a different pattern later. Among restrictive lung diseases, these can further be broken down into intrinsic and extrinsic restrictive disorders.

Obstructive Lung Diseases

The following lung diseases are categorized as being obstructive:

Restrictive Lung Diseases (Intrinsic)

Intrinsic restrictive disorders are those that occur due to restriction in the lungs (often a "stiffening") and include:

Restrictive Lung Diseases (Extrinsic)

Extrinsic restrictive disorders refer to those that originate outside of the lungs. These include impairment caused by:

Restrictive Lung Diseases (Neurological)

Neurological restrictive disorders are those caused by disorders of the central nervous system that prevent the lungs from working properly. Among the most common causes:


A person may also have symptoms and tests that suggest a combination of obstructive and restrictive disease, for example, when a person has both COPD and pneumonia. In addition, some diseases, such as silicosis, cause an obstructive pattern in the early stages of the disease, and a restrictive pattern when the condition is more advanced.


Making a diagnosis of either obstructive or restrictive lung disease begins with a careful history and physical exam, though pulmonary function tests and imaging tests are very important, especially when the diagnosis is unclear. These tests can also sometimes—especially when a mixed pattern is found—help doctors understand if more than one condition is present at the same time. 

Pulmonary Function Tests

Spirometry is a common office test used to evaluate how well your lungs function by measuring how much air you inhale,​ how much you exhale, and how quickly you exhale. It can be very helpful in differentiating obstructive and restrictive lung diseases, as well as determining the severity of these diseases.

Forced Vital Capacity (FVC)

Forced vital capacity (FVC) measures the amount of air a person can breathe out forcefully after taking as deep a breath as possible. Because lung capacity is reduced in both obstructive and restrictive diseases, the FVC alone can not diagnose either disorder.

Forced Expiratory Volume in One Second (FEV1)

Forced expiratory volume in one second (FEV1) measures the total amount of air that can be forcibly exhaled in the first second of the FVC test. Healthy people generally expel around 75 to 85 percent in the first second of the test. The FEV1 is decreased in obstructive lung diseases and normal to minimally decreased in restrictive lung diseases.

FEV1/FVC Ratio

The ratio of FEV1 to FVC measures the amount of air a person can forcefully exhale in one second, relative to the total amount of air he or she can exhale. This ratio is decreased in obstructive lung disorders and normal in restrictive lung disorders. In an adult, a normal FEV1/FVC ratio is 70 percent to 80 percent, and in a child, a normal ratio is 85 percent or greater. The FEV1FVC ratio can also be used to figure out the severity of obstructive lung disease.

Total Lung Capacity (TLC)

Total lung capacity (TLC) is calculated by adding the volume of air left in the lungs after exhalation (the residual volume) with the FVC. TLC is normal or increased in obstructive defects and decreased in restrictive defects. In obstructive lung diseases, air is left in the lungs (air trapping or hyperinflation) causing the increase.

Other Tests

There are other types of pulmonary function tests that may be needed as well.

Lung plethysmography is a test that estimates the amount of air that is left in the lungs after expiration (functional residual capacity) and can be helpful when there is overlap with other pulmonary function tests. It estimates how much air is left in the lungs (residual capacity), which is a measure of the compliance of the lungs (with restrictive airway disease, the lungs are often "stiffer" or less compliant).

Diffusing capacity (DLCO) is another measurement that can be helpful in narrowing down a diagnosis. DLCO measures how well oxygen and carbon dioxide can diffuse between the tiny air sacs in the lungs (alveoli) and the tiny blood vessels (capillaries) in the lungs. The number may be low in some restrictive lung diseases (for example, pulmonary fibrosis) because the membrane is thicker, and low in some obstructive diseases (for example, emphysema) as there is less surface area for this gas exchange to take place.

Obstructive and Restrictive Lung Patterns Chart


Obstructive pattern

Restrictive pattern

Forced vital capacity (FVC)

decreased or normal


Forced expiratory volume
in one second (FEV1)


decreased or normal

FEV1/FVC ratio


normal or increased

Total lung capacity (TLC)

normal or increased



Laboratory Tests

Lab tests may give an indication of the severity of lung disease, but are not very helpful in determining if it is obstructive or restrictive in nature. Oximetry, a measure of the oxygen content in the blood, may be low in both types of diseases. Arterial blood gases may also reveal a low oxygen level, and sometimes an elevated carbon dioxide level (hypercapnia). With chronic lung disease, hemoglobin levels are often elevated in an attempt to carry more oxygen to the cells of the body.

Imaging Studies

Tests such as chest X-ray or chest CT scan may give clues to whether a lung disease is obstructive or restrictive if the underlying condition (such as pneumonia or a rib fracture) can be diagnosed.


Bronchoscopy is a test in which a lighted tube (with a camera) is threaded through the mouth and down into the large airways. Like imaging studies, it can sometimes diagnose the underlying condition.


The treatment options are significantly different for obstructive and restrictive lung diseases (though, treatments can vary considerably depending on the particular condition).

With obstructive lung diseases such as COPD and asthma, medications that dilate the ariways (bronchodilators) can be very helpful. Inhaled or oral steroids are also frequently used to reduce inflammation.

Treatment options for restrictive lung diseases are more limited. With extrinsic restrictive lung disease, treatment of the underlying cause, such as a pleural effusion or ascites, may result in improvement. With intrinsic restrictive lung disease such as pneumonia, treatment of the condition may also help. Until recently, there was little that could be done to treat idiopathic fibrosis, but there are now drugs available that can reduce the severity.

Supportive treatment can be helpful for both types of lung diseases, and may include supplemental oxygen, noninvasive ventilation, such as CPAP or BiPAP, or mechanical ventilation.  Pulmonary rehabilitation may be beneficial for those who have COPD or who have had lung cancer surgery. When severe, lung transplantation is also sometimes an option.


The prognosis of obstructive vs restrictive lung diseases depends more on the specific condition than the category of lung disease. With obstructive lung diseases, those that are reversible often have a better prognosis than those that are not reversible.

A Word From Verywell

It can be frustrating if you are thought to have a lung disease but your doctor isn't certain the exact diagnosis, and waiting for the results of tests and studies can cause considerable anxiety. Fortunately, there are many clues doctors can use to separate out obstructive from restrictive lung diseases; a distinction that is important in order to select the best treatment options available.


Kasper, Dennis L.., Anthony S. Fauci, and Stephen L.. Hauser. Harrison's Principles of Internal Medicine. New York: Mc Graw Hill education, 2015. Print.

Kumar, Vinay, Abul K. Abbas, and Jon C. Aster. Robbins and Cotran Pathologic Basis of Disease. Philadelphia: Elsevier-Saunders, 2015. Print.

McCormack, M. Overview of Pulmonary Function Testing in Adults. UpToDate. Updated 02/07/18.

Was this page helpful?